MedPath

A study of Prasrini taila administration through nasal and through anus in treatment of Cervical spondylosis.

Phase 3
Not yet recruiting
Conditions
Other spondylosis,
Registration Number
CTRI/2018/10/015990
Lead Sponsor
National Institute of Ayurveda Jaipur
Brief Summary

The trial is an open label randomized clinical trial. The primary aim of the trial is to compare the efficacy of Nasya Karma(nasal administration) with Prasarini Taila(oil) and efficacy of Matra Basti (anal administration)of Prasarini Taila ( oil) in the management of  Greevastambh  w.s.r. to Cervical Spondylosis. Total 60 patient will be taken for trial. The patient will be randomly divided into two groups of 30 patients each. In group A Nasya Karma with Prasarini  taila in the dose of 8 drops (6ml) in each nostril will be done for 14 days .In group B  Matra Basti( anal administration ) of Prasarini  taila in the dose of 75ml  once a day for 14 days . The primary outcome will be the improvement in  total score of mJOA and range of motion.The patient will be  finally assessed after 45 days  of treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria
  • (1)Patients with features of Greevastambh (Cervical spondylosis) (2)Patients fit for Nasya and Matra Basti.
  • (3)Patients having sign and symptoms supported by X-ray findings as per Visual Analog Scale, Modified Japanese Orthopedic Score).
Exclusion Criteria
  • (1)Patients suffering from rheumatoid arthritis, gout, ankylosing spondylitis.
  • (2)Patients with major systemic disorders.
  • (3)Patients with stenosis of spinal canal, myelopathy.
  • (4)Pregnant women and lactating mother.
  • (5)Patients with any surgical history at cervical region.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
changes in modified Japanes orthopaedic association score (mJOA score) and range of movement45 days
Secondary Outcome Measures
NameTimeMethod
changes in VAS score and global assessement of disease activity.45 days

Trial Locations

Locations (1)

National Institute of Ayurveda, Jaipur

🇮🇳

Jaipur, RAJASTHAN, India

National Institute of Ayurveda, Jaipur
🇮🇳Jaipur, RAJASTHAN, India
Dr Sarvesh Kumar Singh
Principal investigator
8739860237
sarveshksingh21@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.